RICE HALL JAMES & ASSOCIATES, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001230765

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidDiversifiedHigh Turnover how tags are computed

Q3 2025 · 248 positions · Total reported value $1.83B · Top-10 concentration 24.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 77.5% · 9 new · 172 cut · 12 exited

Active Share (vs S&P 500): 98.5% · vs QQQ: 99.5% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -4.7% · vs SPY -6.9% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +5.1% · vs SPY +3.0% · Latest Value $1.89B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2025 13F filing, RICE HALL JAMES & ASSOCIATES, LLC disclosed 248 equity positions with a combined reported value of $1.83B. The filing implies a diversified portfolio: its ten largest positions account for 24.6% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.

The largest disclosed positions as of Q3 2025 were ARLO ($58.91M), ACIW ($52.59M), LGND ($52.17M). By sector, the heaviest allocations are Health Care 26.8%, Consumer Discretionary 26.8%. Versus the prior quarter, allocation shifted toward Technology (+3.4pp), Health Care (+2.5pp) and away from Financials (-0.8pp), Consumer Discretionary (-1.6pp).

Versus the prior quarter, RICE HALL JAMES & ASSOCIATES, LLC opened 9 new positions, trimmed 172 and fully exited 12, a turnover rate of 77.5% of positions. The portfolio's overlap with the prior quarter was 90% of names.

The largest new positions opened in Q3 2025 were SRAD ($21.50M), QDEL ($7.63M), CRNX ($7.25M).

Of the 12 positions fully exited versus the prior quarter, the largest were OLO ($4.38M), CBZ ($2.81M), PRMB ($2.72M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • SRAD SPORTRADAR GROUP AG · $21.50M
  • QDEL QUIDELORTHO CORP · $7.63M
  • CRNX CRINETICS PHARMACEUTICALS IN · $7.25M
  • PL PLANET LABS PBC · $4.39M
  • ICHR ICHOR HOLDINGS · $3.88M
  • AMPH AMPHASTAR PHARMACEUTICALS IN · $3.45M
  • LZ LEGALZOOM COM INC · $3.40M
  • BLND BLEND LABS INC · $3.04M

Fully Exited (vs previous quarter)

  • OLO OLO INC · prev qtr: $4.38M
  • CBZ CBIZ INC · prev qtr: $2.81M
  • PRMB PRIMO BRANDS CORPORATION · prev qtr: $2.72M
  • HRMY HARMONY BIOSCIENCES HLDGS IN · prev qtr: $2.41M
  • PTLO PORTILLOS INC · prev qtr: $2.22M
  • ACLS AXCELIS TECHNOLOGIES INC · prev qtr: $2.21M
  • AIOT POWERFLEET INC · prev qtr: $1.60M
  • AVNS AVANOS MED INC · prev qtr: $1.45M

Insider Transactions (Form 4)

Latest RICE HALL JAMES & ASSOCIATES, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rice Hall James & Associates, based in San Diego, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 240 positions worth $2.05B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN DIEGO, CA, United States
  • SEC registration: 801-61905 (status: Approved), registered 2003-02-13
  • Regulatory AUM (Form ADV): $1.74B as of 2026-05-06
  • Client mix (by RAUM): pension and profit-sharing plans 62%, individual investors 30%
  • Website: ricehalljames.com

Portfolio Structure

  • 240 positions · $2.05B reported value (Q2 2026)
  • Top 10 holdings = 24.1% of reported value
  • Largest position: LGND (LIGAND PHARMACEUTICALS INC) at 4.2%
  • Average position size: $8.56M

Sector Tilt

  • Health Care 31.6%
  • Consumer Discretionary 25.0%
  • Information Technology 20.2%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 12 new, 94 added, 97 reduced, 15 exited
  • 37 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 26.8%
Technology 19.9%
Financials 3.7%
Other 9.2%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 3.48M $58.91M 3.21%
3.21%
Reduce
2 996.57K $52.59M 2.87%
2.87%
Add
3 294.49K $52.17M 2.85%
2.85%
Reduce
4 91.41K $47.00M 2.56%
2.56%
Reduce
5 305.35K $45.48M 2.48%
2.48%
Reduce
6 584.23K $45.22M 2.47%
2.47%
Add
7 110.95K $40.45M 2.21%
2.21%
Reduce
8 759.07K $39.04M 2.13%
2.13%
Reduce
9 201.99K $35.88M 1.96%
1.96%
Add
10 176.66K $34.63M 1.89%
1.89%
Reduce
11 962.25K $32.12M 1.75%
1.75%
Reduce
12 509.67K $31.80M 1.73%
1.73%
Reduce
13 760.20K $31.16M 1.70%
1.70%
Reduce
14 147.09K $29.24M 1.59%
1.59%
Reduce
15 395.56K $28.93M 1.58%
1.58%
Reduce
16 223.59K $28.90M 1.58%
1.58%
Reduce
17 753.20K $28.70M 1.56%
1.56%
Reduce
18 173.99K $27.41M 1.50%
1.50%
Reduce
19 3.43M $27.07M 1.48%
1.48%
Add
20 130.53K $26.12M 1.43%
1.43%
Reduce
21 129.09K $26.07M 1.42%
1.42%
Reduce
22 476.08K $22.75M 1.24%
1.24%
Reduce
23 577.82K $22.44M 1.22%
1.22%
Reduce
24 799.22K $21.50M 1.17%
1.17%
New
25 238.01K $20.90M 1.14%
1.14%
Reduce
26 667.84K $20.40M 1.11%
1.11%
Reduce
27 239.29K $19.63M 1.07%
1.07%
Reduce
28 110.09K $18.49M 1.01%
1.01%
Reduce
29 334.04K $18.44M 1.00%
1.00%
Reduce
30 851.66K $18.38M 1.00%
1.00%
Add
31 493.61K $17.63M 0.96%
0.96%
Reduce
32 115.72K $17.31M 0.94%
0.94%
Add
33 645.13K $17.09M 0.93%
0.93%
Reduce
34 183.24K $16.74M 0.91%
0.91%
Hold
35 333.69K $16.08M 0.88%
0.88%
Reduce
36 1.73M $16.01M 0.87%
0.87%
Add
37 178.19K $15.59M 0.85%
0.85%
Reduce
38 338.94K $14.89M 0.81%
0.81%
Add
39 71.03K $14.81M 0.81%
0.81%
Reduce
40 1.88M $14.27M 0.78%
0.78%
Reduce
41 681.73K $14.21M 0.78%
0.78%
Reduce
42 99.47K $13.96M 0.76%
0.76%
Reduce
43 444.38K $13.38M 0.73%
0.73%
Reduce
44 258.65K $13.19M 0.72%
0.72%
Reduce
45 614.94K $13.12M 0.72%
0.72%
Reduce
46 465.16K $12.76M 0.70%
0.70%
Add
47 164.75K $12.08M 0.66%
0.66%
Reduce
48 412.00K $11.66M 0.64%
0.64%
Reduce
49 385.34K $11.56M 0.63%
0.63%
Reduce
50 79.67K $11.47M 0.63%
0.63%
Reduce

FAQ

What did RICE HALL JAMES & ASSOCIATES, LLC buy in 2025-Q3?

In its 2025-Q3 13F filing, RICE HALL JAMES & ASSOCIATES, LLC reported 248 equity positions worth $1.83B in aggregate; its largest disclosed positions were ARLO ($58.91M), ACIW ($52.59M), LGND ($52.17M).

How large is RICE HALL JAMES & ASSOCIATES, LLC's portfolio?

RICE HALL JAMES & ASSOCIATES, LLC reported $1.83B of long equity holdings across 248 positions as of 2025-Q3. Top-10 holdings account for 24.6% of reported value.

What is RICE HALL JAMES & ASSOCIATES, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rice-hall-james-and-associates/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →